GENEVA, Feb. 17 -- CINCLUS PHARMA HOLDING AB (PUBL) (Kungsbron 1, Level 3, Elevator G111 22 Stockholm) filed a patent application (PCT/EP2025/072496) for "FORMULATION OF LINAPRAZAN GLURATE" on Aug 05, 2025. With publication no. WO/2026/032974, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KENCHAPPA, Ramesh (c/o Lonza Small Molecules4910 Savarese CircleTampa, Florida 33634), WILLIAMSON, Jeffrey (c/o Lonza Small Molecules4910 Savarese CircleTampa, Florida 33634), SELVARAJ, Karthikeyan (c/o Lonza Small Molecules4910 Savare...